Denver – The University of Colorado’s Anschutz Health and Wellness Center is enrolling patients with diabetes for a first-of-its-kind trial for a new treatment of the disease. The trial is for EndoBarrier, a thin, flexible, tubed-shaped liner that forms a barrier between food and a portion of the intestinal wall, according to KDVR in Denver, Colorado.
The report goes on to say that more than 300,000 people in Colorado are living with diabetes, and according to the CDC, the obesity rates in Colorado have doubled since 1995.
“Most of the time when someone does have Type 2 diabetes, they also have obesity,” says one health expert. “So it’s really putting those two conditions together.”
